Skip to main content

Matinas Biopharma Holdings, Inc (MTNB) Stock

Matinas Biopharma Holdings, Inc Stock Details, Movements and Public Alerts

Stock Details

Matinas Biopharma Holdings, Inc (MTNB), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the ASE.Currently, the stock is trading at $0.17. Over the past 52 weeks, it has ranged between $0.15 and $2.14. This places the current price at 7.9% of its 52-week high and 13.0% above its 52-week low. Recent trading volume was recorded at 1,394,091. The 14-day Relative Strength Index (RSI) stands at 32.71, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.28 by 39.29%. Similarly, it is below its 200-day moving average of $0.56 by 69.64%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: -0.03, Signal Line: -0.04). There are currently 2 active alerts set for MTNB by users.

52-Week Range

$2.14 - $0.15

-92.06% from high · +12.96% from low

Avg Daily Volume

1,418,659

20-day average

100-day avg: 3,627,527

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-0.05

Price to Book

0.57

EV/EBITDA

-0.24

EPS (TTM)

-$1.15

Beta

1.70

More volatile than market

Q:How is MTNB valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is MTNB's risk profile compared to the market?
With a beta of 1.70, Matinas Biopharma Holdings, Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 17% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 0.57 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-6,662,000

Return on Equity

-141.24%

Return on Assets

-56.17%

Q:How profitable and efficient is MTNB's business model?
Profitability metrics are not available for this stock.
Q:What are MTNB's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$2.4M

Shares Outstanding

14.69M

Book Value/Share

$0.28

Asset Type

EQUITY

Q:What is MTNB's market capitalization and position?
Matinas Biopharma Holdings, Inc has a market capitalization of $2.4M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 14.69M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does MTNB's price compare to its book value?
Matinas Biopharma Holdings, Inc's book value per share is $0.28, while the current stock price is $0.17, resulting in a price-to-book (P/B) ratio of 0.60. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Sep 16, 2026, 02:03 AM

Technical Indicators

RSI (14-day)

32.71

Neutral

50-Day Moving Average

$0.28

-39.29% below MA-50

200-Day Moving Average

$0.56

-69.64% below MA-200

MACD Line

-0.03

MACD Signal

-0.04

MACD Histogram

0.01

Bullish

Q:What does MTNB's RSI value tell investors?
The RSI (Relative Strength Index) for MTNB is currently 32.71, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret MTNB's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.03 above the signal line at -0.04, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.28) is below the 200-day MA ($0.56), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Sep 16, 2026, 01:23 AM

Active Alerts

Alert Condition
MA Breakout (Bullish)
Threshold
50 days
Created
Aug 27, 2026, 04:03 PM
Alert Condition
Volume change
Threshold
200%
Created
Aug 24, 2026, 03:59 PM

Stay Ahead of the Market with Matinas Biopharma Holdings, Inc Alerts

Set up price alerts for Matinas Biopharma Holdings, Inc and get notified instantly when the price hits your target. Never miss an important price movement again.